Author:
Bosch Xavier,Marrugat Jaume,Sanchis Juan
Reference188 articles.
1. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study;Valgimigli;Circulation,2009
2. Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design;Valgimigli;Cardiovascular Drugs and Therapy,2008
3. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone;Antoniucci;Circulation,2004
4. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction;Antoniucci;Journal of the American College of Cardiology,2003
5. The ADMIRAL study: abciximab with percutaneous transluminal coronary angioplasty and stent in acute myocardial infarction;Montalescot;American Heart Journal,1999
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献